Company / Current Liabilities
Connect Biopharma Holdings Ltd Current Liabilities History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$13.6M
FY2025
5-year range
$8.5M / $13.6M
FY2024-FY2025
Trend
+60.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$14M in FY2025.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities increased 60.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.6M | +60.9% |
| FY2024 | $8.5M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026